D. Gossage

发表

MEDI-563, a humanized anti-IL-5 receptor alpha mAb with enhanced antibody-dependent cell-mediated cytotoxicity function.

C. Mackay, Herren Wu, R. Woods, 2010, The Journal of allergy and clinical immunology.

Clinical Trial Simulation To Assist In COPD Trial Planning And Design With A Biomarker-Based Diagnostic: When To Pull The Trigger?

Harry Yang, J. Parker, D. Gossage, 2014, COPD.

Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials.

P. Thompson, A. O'donnell, W. Boersma, 2014, The Lancet. Respiratory medicine.

Adjunct antibody administration with standard treatment reduces relapse rates in a murine tuberculosis model of necrotic granulomas

V. Saini, B. Carr, A. Ordonez, 2018, PloS one.

Monoclonal antibody therapy directed against interleukin-5 receptor α: MEDI-563

P. Kiener, M. Koike, A. Coyle, 2010 .

Assessment of Drug Resistance during Phase 2b Clinical Trials of Presatovir in Adults Naturally Infected with Respiratory Syncytial Virus

R. Jordan, T. Watkins, Jason K. Perry, 2020, Antimicrobial Agents and Chemotherapy.

Molecular and clinical rationale for therapeutic targeting of interleukin‐5 and its receptor

R. Kolbeck, N. Molfino, J. Parker, 2012, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia.

W. Busse, S. Wenzel, G. Gauvreau, 2013, The Journal of allergy and clinical immunology.

Discriminating sputum-eosinophilic asthma: Accuracy of cutoffs in blood eosinophil measurements versus a composite index, ELEN.

W. Busse, D. Khatry, N. Jarjour, 2015, The Journal of allergy and clinical immunology.

The association of blood eosinophil counts to future asthma exacerbations in children with persistent asthma.

D. Khatry, M. Schatz, R. Zeiger, 2015, The journal of allergy and clinical immunology. In practice.

Effects of benralizumab on airway eosinophils in asthma with sputum eosinophilia

W. Busse, G. Gauvreau, M. Laviolette, 2014 .

High blood eosinophil count is a risk factor for future asthma exacerbations in adult persistent asthma.

D. Khatry, M. Schatz, R. Zeiger, 2014, The journal of allergy and clinical immunology. In practice.

Two phase 3 placebo-controlled trials of aztreonam lysine for inhalation (AZLI) for non-cystic fibrosis bronchiectasis (NCFB)

P. Thompson, A. O'donnell, W. Boersma, 2013 .

Depletion Of Airway Eosinophils By Benralizumab An Anti-IL5 Receptor Alpha Monoclonal Antibody

G. Gauvreau, M. Laviolette, R. Leigh, 2012, ATS 2012.

Transcriptional regulation of type I collagen genes in cultured fibroblasts by a factor isolated from thioacetamide-induced fibrotic rat liver.

J. Seyer, R. Raghow, A. Kang, 1984, The Journal of biological chemistry.

Pathology of the pancreas in severe combined immunodeficiency and DiGeorge syndrome: acute graft-versus-host disease and unusual viral infections.

K. Washington, M. Gottfried, D. Gossage, 1994, Human pathology.

Pathology of the liver in severe combined immunodeficiency and DiGeorge syndrome.

K. Washington, M. Gottfried, D. Gossage, 1993, Pediatric pathology.

A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients

A. Limaye, M. Boeckh, G. Rahav, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

High blood eosinophil count is associated with more frequent asthma attacks in asthma patients.

D. Khatry, T. Tran, D. Gossage, 2014, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor alpha antibody, in a phase I study of subjects with mild asthma.

W. Busse, P. Kiener, M. Koike, 2010, The Journal of allergy and clinical immunology.

A 26-month-old child with Marden-Walker syndrome and pyloric stenosis.

M. Butler, J. Perrin, D. Gossage, 1987, American journal of medical genetics.

Delayed onset and recurrent Alcaligenes xylosoxidans keratitis.

D. Gossage, S. Dunn, D. Heidemann, 2000, Cornea.

Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study.

W. Busse, E. Bleecker, D. Khatry, 2014, The Lancet. Respiratory medicine.

Prevalence of lymphocytopenia in severe combined immunodeficiency.

R. Buckley, D. Gossage, Rebecca H. Buckley, 1990, The New England journal of medicine.

Identification of a murine homolog of the human adenosine deaminase thymic enhancer.

A. Brickner, D. Wiginton, D. Gossage, 1995, Gene.

Pretranslational regulation of type I collagen, fibronectin, and a 50-kilodalton noncollagenous extracellular protein by dexamethasone in rat fibroblasts.

R. Raghow, A. Kang, D. Gossage, 1986, The Journal of biological chemistry.

Phase 1b Study of the Safety, Pharmacokinetics, and Disease-related Outcomes of the Matrix Metalloproteinase-9 Inhibitor Andecaliximab in Patients With Rheumatoid Arthritis.

Y. Xin, J. Sundy, P. Lal, 2018, Clinical therapeutics.

A homozygous 5 base-pair deletion in exon 10 of the adenosine deaminase (ADA) gene in a child with severe combined immunodeficiency and very low levels of ADA mRNA and protein.

M. Hershfield, M. Markert, D. Gossage, 1993, Human molecular genetics.

1646. Combined Resistance Analyses From Phase 2b Studies of Presatovir Treatment in RSV-Infected Adults

R. Jordan, T. Watkins, Jason K. Perry, 2018, Open Forum Infectious Diseases.